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Abstract
Genetic manipulation of organisms using CRISPR/Cas9 technology generally produces
small insertions/deletions (indels) that can be difficult to detect. Here, we describe a tech-
nique to easily and rapidly identify such indels. Sequence-identified mutations that alter a
restriction enzyme recognition site can be readily distinguished from wild-type alleles using
a cleaved amplified polymorphic sequence (CAPS) technique. If a restriction site is created
or altered by the mutation such that only one allele contains the restriction site, a polymerase
chain reaction (PCR) followed by a restriction digest can be used to distinguish the two
alleles. However, in the case of most CRISPR-induced alleles, no such restriction sites are
present in the target sequences. In this case, a derived CAPS (dCAPS) approach can be
used in which mismatches are purposefully introduced in the oligonucleotide primers to
create a restriction site in one, but not both, of the amplified templates. Web-based tools
exist to aid dCAPS primer design, but when supplied sequences that include indels, the cur-
rent tools often fail to suggest appropriate primers. Here, we report the development of a
Python-based, species-agnostic web tool, called indCAPS, suitable for the design of PCR
primers used in dCAPS assays that is compatible with indels. This tool should have wide util-
ity for screening editing events following CRISPR/Cas9 mutagenesis as well as for identify-
ing specific editing events in a pool of CRISPR-mediated mutagenesis events. This tool was
field-tested in a CRISPR mutagenesis experiment targeting a cytokinin receptor (AHK3) in
Arabidopsis thaliana. The tool suggested primers that successfully distinguished between
wild-type and edited alleles of a target locus and facilitated the isolation of two novel ahk3
null alleles. Users can access indCAPS and design PCR primers to employ dCAPS to iden-
tify CRISPR/Cas9 alleles at http://indcaps.kieber.cloudapps.unc.edu/.
Introduction
It is often necessary to genotype biological samples to select individuals from a large population
with a desired genetic variant. Genetic variants generated by mutagenesis or natural variation can
take the form of single nucleotide polymorphisms (SNPs) or insertions/deletions (indels). Suffi-
ciently large indels can be distinguished using PCR followed by agarose or polyacrylamide gel
electrophoresis (PAGE), but differences of one or two base pairs can be difficult to distinguish
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reliably even with PAGE, and SNP alleles are refractory to size-based genotyping. Diagnostic
tools for genotyping samples with SNPs or small indels include PCR-based cleaved amplified
polymorphic sequences (CAPS) or derived CAPS markers (dCAPS) [1]. A typical CAPS assay
consists of a short amplicon centered on a restriction site present in only one genotype. The
CAPS assay identifies the genotype of the individual based on whether or not the PCR product
is cleaved by the differential restriction enzyme (Fig 1A). A dCAPS assay can be used if there are
no restriction sites differentially present in the wild-type and mutant genomic sequences. The
dCAPS assay introduces or disrupts a restriction enzyme motif near the mutation by amplifying
the target sequences using an oligonucleotide primer that includes one or more mismatches rela-
tive to the template (Fig 1B). The mismatches are chosen so that following amplification, a restric-
tion site is introduced into either the wild-type or the mutant amplified fragment, which can then
be distinguished by restriction enzyme digestion followed by agarose gel electrophoresis.
As CRISPR/Cas9-generated mutant alleles become more prevalent, there is a growing need
for a facile method for screening and genotyping indel alleles [2–5]. Assays based on dCAPS
markers are ideal for this as they are simple, robust, inexpensive, and relatively high throughput.
However, designing productive primers for allele-specific dCAPS assays can be cumbersome.
Here, we present the development of a new web-based tool to design dCAPS primers for
indels that should be of general utility for analysis of CRISPR/Cas9-generated mutant alleles in
any species. We demonstrate the utility of this tool using CRISPR/Cas9 targeting of the AHK3
locus in Arabidopsis thaliana. AHK2, AHK3, and AHK4 are the three receptors present in
Fig 1. CAPS/dCAPS markers can distinguish alleles, but output of dCAPS Finder 2.0 can be flawed. (A) Diagram of CAPS technique. An
amplicon centered on a restriction site (blue bar) disrupted by a SNP or indel (red bar) is differentially cleaved by a restriction enzyme (RE) in the wild-
type vs mutant. (B) Diagram of the dCAPS technique. A restriction site can be introduced into either the wild-type or mutant target sequences using
mismatched oligonucleotide primers to discriminate two sequences. The mutation (green bar) disrupts the introduced restriction site such that it is not
cleaved by the restriction enzyme (RE). Gel electrophoresis can be used to identify the size difference between the wild-type and mutant fragments in
both the CAPS and dCAPS methods. (C-F) A sequence with a two base pair deletion at a CRISPR cut site, chosen using CRISPR-Plant [12], was
supplied to dCAPS Finder 2.0 with a mismatch allowance of 1 base pair. A minority of proposed assays are viable (C), but others possess too many
mismatches for successful amplification by PCR or do not introduce diagnostic restriction sites (D-F).
https://doi.org/10.1371/journal.pone.0188406.g001
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Arabidopsis that are involved in the perception of cytokinin, a plant hormone regulating a
diverse set of biological functions in plants [6]. Previous studies have identified null alleles of
ahk2 and ahk4, but the previously identified ahk3-3 allele is hypomorphic rather than a null
allele, as residual full-length AHK3 transcript was found to be present in ahk3-3 seedlings [7].
Primers generated by the indCAPS tool were successfully used to identify editing events at the
AHK3 locus, and viable triple null mutant lines for the cytokinin histidine kinase receptors
were identified. The indCAPS tool has the potential to be an important resource for investiga-
tors seeking to find new CRISPR alleles or design genotyping primers for known alleles.
Materials and methods
Software
The indCAPS package was written in Python (version 3.5.2) and is implemented as a web
application using the flask framework (0.12), the bleach package (1.5.0) for input scrubbing,
and the gunicorn WSGI HTTP server (19.7.1). It is provided through an OpenShift application
platform available from UNC-Chapel Hill. The website is available at http://indcaps.kieber.
cloudapps.unc.edu. The source code is available at https://github.com/KieberLab/indCAPS.
Plant growth and transformation
Plants were grown at 21˚C in long days (16 h light). The ahk2-7 cre1-12 double mutant was
transformed with pCH59, a pCUT series binary expression vector containing AHK3-targeting
gRNA sequences and expressing plant codon optimized Cas9 [8], by the floral dip method [9].
Putative transformants were selected on Murashige and Skoog media containing 50 μg/ml
hygromycin and then transferred to soil and allowed to set seed. T2 seeds were plated on Mur-
ashige and Skoog plant growth media (2400 mg/L MS salts, 250 mg/L MES buffer) [10], and
then seedlings were transplanted to soil and genotyped for editing at the AHK3 locus.
Detection of ahk3 mutations using dCAPS
Oligonucleotide primers were designed to detect editing at the AHK3 locus using the indCAPS
tool. Amplification of the AHK3 locus was performed with primers AHK3.dC.F and AHK3.
dC.rc (data in S1 Text) followed by digestion of the amplicon with Bsa BI. Digests were ana-
lyzed using gel electrophoresis with a 3% agarose gel. Lines lacking any wild-type digestion
pattern were selected for analysis. Sanger sequencing was used to characterize editing events as
single base-pair indels and to confirm homozygosity.
Results and discussion
dCAPS Finder 2.0 has poor compatibility with indel alleles
While a web tool for the design of dCAPS primers has been described [11], it was designed pri-
marily to detect SNP alleles. Primers generated with the tool for small indels often will not
actually amplify either the wild-type or mutant sequences by PCR, or in some cases will not
actually distinguish between the wild-type and mutant sequences. For example, an analysis of
potential dCAPS primers generated by the existing dCAPS program (http://helix.wustl.edu/
dcaps/dcaps.html) for indels in several genes in A. thaliana demonstrated that as few as 15% of
the suggested primers are capable of distinguishing the provided alleles (AHK3, 50% capable;
CENH3, 14%; AGO1, 17%; MED20, 13%; RB1, 15%, see Table 1 for further details). Primers
from dCAPS Finder 2.0 were examined by constructing the amplicons which the primer
would generate in both the wild-type and an edited sequence and examining the amplicons for
utility in a CAPS or dCAPS assay. Many of the primer pairs are non-functional and either do
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not generate a diagnostic restriction site or likely would not amplify the target DNA due to
alignment gaps or extensive 3’ mismatches between the primer and one of the template
sequences (Fig 1C–1F). There are workaround methods for dCAPS Finder 2.0 in which the
user supplies two sequences in which the terminal base is the indel, rather than placing the
indel in the middle of the provided sequences. This approach will ignore any potential assays
in which a restriction motif may overlap the indel site, as the program has no information
about bases on the other side of the indel. The reason dCAPS Finder 2.0 falters on indel alleles
is not clear as the source code is no longer available.
A web-based tool for design of primers to detect indels: indCAPS
A new software package, indCAPS, was developed to facilitate the design of dCAPS primers
for indels. This software has also been adapted for the design of CAPS and dCAPS oligonucle-
otide primers used in PCR amplification of target sequences in order to screen for editing
events following CRISPR/Cas9-mediated mutagenesis [13]. The tool is available at http://
indcaps.kieber.cloudapps.unc.edu.
The interface presents two dialog boxes to the user. The first box is for the generation of
dCAPS primers for known alleles. The second box is for the generation of dCAPS primers
for detecting unknown alleles. The first box requires the user to submit two sequences. No
assumptions are made about either sequence being a wild-type or mutant allele, so order does
not matter. Ideally, each sequence is centered on the mutation of interest. The two sequences
do not need to be the same length, but should have homology arms of at least 20 bases flanking
the mutation of interest. The user is also asked to submit a maximum number of mismatches
in the primer. The default value is 1 mismatch. Increasing the maximum mismatch value
should result in more enzymes being reported, but as with any dCAPS assay, this may result in
primers which are less likely to successfully amplify DNA.
Several advanced options are also available. Amplicon length can be specified. This parame-
ter dictates how far downstream the tool examines the sequence when looking for exact
matches for each restriction site. A restriction enzyme is rejected if there is a cleavage site in
the shared downstream region, which would complicate the analysis of the diagnostic cleavage
at the site of interest. Depending on the size of the submitted sequence, the amplicon length
may be longer than the sequence available to the program. In this case, the entire submitted
sequence downstream of the primer is considered. If the user intends to use a paired primer
lying outside the sequence supplied to the program, the user should check that either no exact
restriction digests are present in the region not shown to the program or any exact restriction
sites will still permit discrimination between diagnostic bands when analyzed with gel electro-
phoresis. Primers can be chosen based on a strict primer length or by a target melting tempera-
ture. A target size may be desired if the user wishes to ensure that a sufficiently large fragment
will be cleaved. This may be useful in GC rich areas where a primer designed to match a target
Table 1. Number of productive primers generated for tested loci. Simulated amplicons were made using generated primers. Non-productive primers did
not amplify sequences capable of being distinguished with a restriction digest. Problematic primers amplify sequences capable of being distinguished, but the
reaction would likely not amplify DNA due to primer defects such as 3’ mismatches or gaps in alignment to provided sequence. Productive primers are
expected to successfully amplify DNA capable of being distinguished by a restriction digestion.
Gene Locus Target Sequence Productive primers Problematic primers Non-productive primers
AHK3 AT1G27320 GGTTGAGATCAAGATAGACA 8 3 5
CENH3 AT1G01370 TCACAACCTCGGAATCAAAC 3 3 22
AGO1 AT1G48410 GAGCCTTCACCTCCTTCAGA 2 5 29
MED20 AT2G28230 GGCTGCTTACTGTTGATCCT 0 3 20
RB1 AT3G12280 CCCATTTGGTTCAATGGGCG 5 1 35
https://doi.org/10.1371/journal.pone.0188406.t001
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melting temperature would be short, resulting in small shifts in band sizes after cleavage and
electrophoresis. Melting temperature calculations are performed using the Nearest Neighbor
method [14] using thermodynamic parameters published by Sugimoto et al. [15], as imple-
mented in the Oligo Calc tool [16]. It is necessary to assume certain information about the
primer concentration and sodium ion concentration in the PCR reaction to calculate the melt-
ing temperature. Default values have been provided, but those parameters can be modified as
necessary by the user through the web interface. Also, primers which contain terminal 3’ mis-
matches are rejected by default. Some researchers have reported that certain terminal 3’ mis-
matches are compatible with PCR [17–19], but due to inconsistencies in the literature, the
default assumption for this tool is that 3’ mismatches will not amplify. If the user wishes to
allow certain 3’ mismatches, the option is available. If enabled, 3’ G/T mismatches are ignored.
The second box presented by the tool to the user permits screening for mutagenesis events
in a CRISPR-mediated mutagenesis experiment. The box requires the user to submit the wild-
type genomic sequence the user intends to target. The sequence should contain at least twenty
bases on each side of the cleavage site. The user should also include the CRISPR target site ori-
ented 5’ to 3’, not including the PAM. The CRISPR target sequence is not required to be in the
same orientation as the wild-type sequence. The tool assumes that the last base of the provided
sequence immediately precedes the PAM if aligned to the wild-type sequence and that cleavage
occurs at the -3 position. The mismatch max parameter behaves as it does in the first box. The
final major parameter is the acceptable loss threshold, which is the percent of editing events
the user is willing to miss with their screening. Lower values mean the user wants to detect
more editing events. Higher values mean the user is willing to accept missing certain editing
events. Missed editing events, in this context, are most likely to occur if an insertion event
occurs relative to an enzyme with degenerate bases in its recognition motif. The advanced
options are the same as for those in the first box.
An additional application is facilitated by the first box, the known-alleles tool. CRIPSR-
mediated mutagenesis events create random mutations at the target locus. It may be desired in
some cases to generate an isogenic mutation in a novel biological context, such as a different
ecotype or genetic background. This is especially useful in cases where multiple mutant loci
must be maintained and introducing an isogenic mutation would prove easier than screening
multiple segregating loci as a result of a cross. The output of the known-alleles tool indicates
which of the two supplied sequences is cleaved by the restriction digest. If the user supplies the
wild-type sequence and the specific mutant sequence they wish to find and choose an assay
where the mutant sequence is cleaved, then a CAPS/dCAPS assay can be used to screen a pool
of CRISPR-generated mutants for a specific mutation. This could be feasibly accomplished by
a two-step process, where primers generated by the unknown allele indCAPS application are
used to screen for lines showing any evidence of CRISPR-mediated editing events, and then a
second primer set is used to screen for a specific mutation within that population.
After analysis is complete, the user may be presented with several candidate primers. The
user is required to choose their own downstream primer. Currently, the primers are evaluated
only by their length or melting temperature, depending on the user’s specification.. The user
can choose any of the reported primers, but may prefer certain assays over others due to cost
or availability of the enzyme, compatibility of the enzyme with their PCR conditions, or per-
sonal preference in enzyme choice.
Technical details of the indCAPS package
A general outline of the algorithm that was developed is illustrated in Fig 2. The user-supplied
sequences (based on the mutagenesis target) are compared by defining shared and unshared
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Fig 2. Algorithm for generation of oligonucleotide primers useful for CAPS and dCAPS assays. Two user-
supplied sequences are analyzed, with one end near the predicted mutation site. Shared and unshared regions are
identified in each sequence. A sub-sequence near the last shared base from each direction is isolated and compared to a
library of restriction enzyme recognition motifs (https://www.neb.com/tools-and-resources/selection-charts/alphabetized-
list-of-recognition-specificities). If a diagnostic site is detected, determined by an exact or close motif match in only one
sequence, a primer is generated. The primer disrupts any exact matches present in the shared regions and is checked to
ensure the mismatch number is less than the specified maximum.
https://doi.org/10.1371/journal.pone.0188406.g002
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regions in each sequence. In the case of a SNP allele, each sequence will have an unshared
region of one base. For indel alleles, the sequence with the deletion relative to the other will
have an unshared region of 0 bases and the sequence with the relative insertion will have an
unshared region equal to the number of inserted bases.
Two core assumptions are made when designing diagnostic assays: 1) designed primers must
be wholly contained in the shared region; and 2) putative restriction sites must have at least one
base pair of overlap with both the shared and unshared regions. A library of restriction enzyme
recognition sites (https://www.neb.com/tools-and-resources/selection-charts/alphabetized-list-
of-recognition-specificities) (excluding nicking or double-cutting enzymes) is compared to both
shared regions and to a subsequence near the last shared base. Sequences are compared using a
modified Hamming distance metric, where the number of non-similar bases is counted, allowing
for degeneracy. For example, the sequences GCAT and GGTT have a distance of 2, and the
sequences GCAT and GYTT have a distance of 1. Each recognition site is iterated across the sub-
sequence and the distance at each position is calculated. If the distance for a comparison is below
the user-specified mismatch threshold, that position is stored as a potential assay. An enzyme is
rejected if it cuts in the downstream shared region, and exact matches in the primer are dis-
rupted with mismatches during the primer design stage. Each set of sequences is analyzed twice,
once as supplied, and again using the reverse complement of each sequence. An enzyme that is
rejected because it cuts in the shared, downstream region of both sequences from one direction
may be suitable if the primer is aligned to the reverse complement of the two sequences. For effi-
ciency purposes, primers are designed only if a potential CAPS/dCAPS assay is detected in com-
parisons of the input sequences; the number of comparisons made is reduced if primers are
designed for specific assays rather than designing all possible primers and assessing them for
compatibility with CAPS/dCAPS assays. Primers are designed with their 3’ end at the last shared
base of the two sequences. The primer length is then extended in the 5’ direction to generate can-
didate output primers. Each candidate primer is assessed by its length or melting temperature,
according to the user’s choice, and the primer best matching the chosen criterion is reported.
For the purpose of CRISPR/Cas9 screening, a profile of possible editing events is used to
simulate editing events in the wild-type sequence. Currently, the default editing events are
single base pair insertion and deletion events. Future versions of the software will allow the
user to supply a custom profile of events. The user is required to provide the specific target
sequence used in CRISPR/Cas9 mutagenesis and the cut site is assumed to be at the -3 position
of the provided 20-bp target [13]. All possible sequence variants are created and compared to
the wild-type sequence to identify the last shared base. The last shared base is taken to be the
last base in the wild-type sequence shared with all sequence variants. A simplifying assumption
is made when designing primers for unknown alleles: cleavage will occur in the wild-type
sequence and will be disrupted in mutant sequences.
Use of indCAPS to find mutants in cytokinin signaling
Cytokinins, a class of adenine-derived signaling molecules are involved in regulating a diverse
set of biological processes. Cytokinins are perceived by Arabidopsis Histidine Kinase (AHK)
proteins [20, 21] in the endoplasmic reticulum [22, 23], which undergo autophosphorylation
on a His residue. This phosphate is ultimately transferred to either type-A or type-B Response
Regulator proteins (ARRs) via the Histidine Phosphotransfer (AHP) proteins [24–26]. Type-B
ARRs are transcription factors activated by phosphorylation [27]. Type-A ARRs lack a DNA-
binding domain, are cytokinin-inducible, and negatively regulate cytokinin signaling [28, 29].
The cytokinin AHK receptors are encoded by AHK2, AHK3, and AHK4/CRE1 in Arabidop-
sis. Multiple mutant lines with various loss-of-function T-DNA insertion alleles of each gene
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have been identified. The most severely affected triple mutant line, , ahk2-7 ahk3-3 cre1-12,
harbors null alleles for ahk2 and ahk4, but still contains residual full-length wild-type tran-
script for AHK3 [7]. We sought to identify a CRISPR-induced null allele of ahk3 in an ahk2
ahk4 background by introducing a frameshift mutation in AHK3. This would reveal the effect
of complete disruption of the AHK cytokinin receptors in Arabidopsis.
The indCAPS tool was tested by designing primers for a CRISPR mutagenesis experiment
targeting the AHK3 gene (Fig 3). A CRISPR/Cas9 target was designed to target the first exon of
Fig 3. Homozygous editing events in AHK3 were identified. (A) The indCAPS package was used to generate a primer recognizing a Bsa BI site
spanning the CRISPR cut site (between the green bases). A single mismatch was required in the primer (indicated in red). The genomic locus for AHK3
is shown. Boxes indicate exons, red bars—transmembrane domains, black region—CHASE domain, grey region—histidine kinase domain, yellow
region—receiver domain, blue region– 3’ UTR. Locations of T-DNA insertion sites (ahk3-1, ahk3-3, and ahk3-7) and targeted editing site are indicated.
(B,C) The assay was used to screen A. thaliana plants stably transformed with a pCUT binary vector system [8] and sgRNA constructs targeting AHK3.
(B) Wild-type controls at edit location. (C) T2 plants from two representative independent transformation events are shown. The uncut amplicon is 90
bp and the wild-type allele is cleaved to produce 36 bp and 54 bp fragments. (D) Progeny from two T2 plants heterozygous for editing events were
selected and analyzed for editing. (E) A. thaliana seedlings imaged at 2.5 weeks of growth. Shown are Col-0; ahk3-3; ahk2,4; ahk2-5 ahk3-7 cre1-12;
ahk2-1/+ ahk3-1 ahk4-1; ahk2-7 ahk3-3/+ cre1-12; ahk2-7 ahk3-9 cre1-12; ahk2-7 ahk3-10 cre1-12. All plants at same scale.
https://doi.org/10.1371/journal.pone.0188406.g003
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AHK3 using the CRISPR-Plant resource [12]. The target site chosen is before the Cyclases/His-
tidine kinases Associated Sensory Extracellular (CHASE) domain, the cytokinin binding
domain of the AHKs. The AHK3 targeting plasmid, pCH59, was stably transformed into an
ahk2-7 cre1-12 mutant line [20, 21, 30], referred to as ahk2,4 hereafter. The pCH59 vector was
constructed by cloning a commercially synthesized gRNA fragment into a pCUT binary vector
system expressing plant codon optimized Cas9 [8]. T1 transformed seedlings were identified
by hygromycin selection and grown to maturity. The T2 progeny were screened for AHK3
editing events using primers generated by indCAPS. Viable seedlings with homozygous, single
base pair insertions causing frameshift mutations disrupting the AHK3 coding region were
identified. These alleles, denoted ahk3-9 and ahk3-10, are single base pair insertions of A and
C, respectively. The frameshift produces an early stop codon 25 residues after the edit location.
The resulting predicted protein retains two transmembrane domains, but no functional
CHASE domain or cytosolic histidine kinase or receiver domains. These triple cre1-12 ahk2-7
ahk3 mutants were viable and resembled the cre1-12 ahk2-7 ahk3-3 [31]. These results demon-
strate that the complete disruption of all three AHK cytokinin receptors does not result in
embryo lethality. As these are the only CHASE-domain containing proteins in Arabidopsis,
this suggests that either cytokinin is not essential for early development, or that there are other
as yet unidentified cytokinin receptors.
In addition to analysis of CRISPR-induced ahk4 alleles, indCAPS tool has been successfully
use by multiple other members of the authors’ research groups to successfully target at least
five additional genes.
Conclusions
The indCAPS package provides a useful tool for researchers using CRISPR-mediated muta-
genesis as it facilitates the screening of individuals in which editing of the target has occurred.
It also provides replacement for existing tools for the design of primers for dCAPS analysis
capable of distinguishing known indel alleles. We employed this tool to successfully design
diagnostic primers to identify CRISPR-induced ahk3 null alleles, the subsequent analysis of
which showed that the cytokinin AHK receptors are not essential for embryo development.
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